Bone Marrow contains a rich source of regenerative cells needed for angiogenesis, optimal bone and cartilage regeneration and healing.

BMAC® is indicated for :

  • Delayed Bone Union
  • Non-Union Bone
  • Spine Fusion
  • Chronic Limb Ischemia

BMAC system produces the highest cell yields available while concentrating the full complement of cells.

  • Concentrates key cells in their natural ratios
  • Maintain cells in their natural plasma for maximum viability
  • Produces consistent and reliable nucleated cell loads
  • Enables the clinician to adjust the cell dose/volume

The cellular Composition of BMAC is virtually equivalent to Autograft

* The production of BMP’s are up-regulated in the fracture site, derived from HSC’s, and members of the TGF-ß superfamily of proteins.

Being Autologous it has a high safety profile

How is the treatment being performed?

Treatment is as simple as 1-2-3. In less than 15 minutes, 30mL of bone marrow aspirate provides 3-4mL of Concentrated Autologous Cells and growth factors.

High Safety Profile


  • The Bone marrow-derived cells are not chemically manipulated or cultured

Closest System to a closed system

  • Follows AABB and FDA/CBER guidelines for transfusion therapy
    Disposables incorporates re-sealable injection ports